Homocysteine and ischaemic heart disease in the Caerphilly cohort

Atherosclerosis

Volumn 140, Issue 2, 1998, Pages 349-356

  Ubbink, Johan B ^a   Fehily, Ann M ^b   Pickering, Janet ^c   Elwood, Peter C ^d   Hayward Vermaak, W J ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b HJ Heinz Co Ltd Wigan   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular diseases; Epidemiology; Heart disease; Homocysteine

Indexed keywords

ALCOHOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; VITAMIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL STATUS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SOCIAL CLASS; UNITED KINGDOM;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; URBAN POPULATION; VITAMINS; WALES;

EID: 0031757990     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00139-7     Document Type: Article

References (36)

1. Mudd SH, Levy HL, Skovby F Disorders of transsulfuration. Scriver CR, Beaudet AL, Sly WS, Valle D The Metabolic Basis of Inherited Disease. 6th edn. 1989;693-734 McGraw-Hill, New York.
2. Rees MM, Rodgers GM Homocysteinemia - association of a metabolic disorder with vascular disease and Thrombosis. Thromb Res. 71:1993;337-359.
3. Ubbink JB, Vermaak WJH, Bennett JM, Becker PJ, van Staden DA, Bissbort S The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr. 69:1991;527-534.
4. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 324:1991;1149-1155.
5. Bienvenu T, Ankri A, Chadefaux B, Kamoun P Plasma homocysteine assay in the exploration of thrombosis in young subjects. Presse Med (Paris). 20:1991;985-988.
6. Stampfer MJ, Malinow R, Willet WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc. 268:1992;877-881.
7. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke. 21:1990;572-576.
8. Bergmark C, Mansoor MA, Swedenborg J, de Faire U, Svardal AM, Ueland PM Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50 - effect of smoking and extent of disease. Eur J Vasc Surg. 7:1993;391-396.
9. Von Eckardstein A, Malinow MR, Upson B, Heinrich J, Schulte H, Schönfeld R, Köhler E, Assman G Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. Arterioscler Thromb. 14:1994;460-464.
10. Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb. 13:1993;1253-1260.
11. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb. 13:1993;1327-1333.
12. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc. 274:1995;1049-1057.
13. Clarke R, Naughten E, Cahalane S, Sullivan KO, Mathias P, McCall T, Graham I The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinemia. Ir J Med Sci. 161:1992;561-564.
14. Hirano K, Ogihara T, Miki M, Yasuda H, Tamai H, Kawamura N, Mino M Homocysteine induces iron-catalyzed lipid peroxidation of low density lipoprotein that is prevented by alpha-tocopherol. Free Radical Res. 21:1994;267-276.
15. Heinecke JW, Kawamura M, Suzuki L, Chait A Oxidation of low density lipoprotein by thiols-superoxide-dependent and superoxide-independent mechanism. J Lip Res. 34:1993;2051-2061.
16. Fehily AM, Yarnell JWG, Sweetnam PM, Elwood PC Diet and incident ischaemic heart disease: the Caerphilly Study. Br J Nutr. 69:1993;303-314.
17. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation. 83:1991;836-844.
18. Yarnell JWG, Fehily AM, Milbank JE, Sweetnam PM, Walker CL A short dietary questionnaire for use in an epidemiological survey: comparison with weighed dietary records. Hum Nutr: Appl Nutr. 37A:1983;103-112.
19. Paul AA Southgate DAT. McCance and Widdowson's The Composition of Foods. 1978;HMSO, London.
20. Araki A, Sako Y Determination of free and total homocysteine in human plasma by HPLC with fluorescence detection. J Chromatogr. 422:1987;43-52.
21. Ubbink JB, Vermaak WJH, Bissbort S Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 565:1991;441-446.
22. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM Plasma concentrations of homocysteine and other aminothiols are related to food intake in healthy human subjects. J Nutr. 124:1994;934-941.
23. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc. 270:1993;2693-2698.
24. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willet WC Homocysteine metabolism and risk of myocardial infarction: Relation with vitamins B-6, B-12 and Folate. Am J Epidemiol. 143:1996;845-859.
25. Arnesen E, Refsum H, Bønaa K, Ueland PM, Førde OH, Nordrehaug JE Serum total homocysteine and coronary heart disease. Int J Epidemiol. 24:1995;704-709.
26. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 106:1994;9-10.
27. Ueland PM, Refsum H, Brattström L Plasma homocysteine and cardiovascular disease. Francis BR Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. 1992;183-235 Marcel Dekker, New York.
28. Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A Systemic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from BUPA study. Br Med J. 308:1994;363-366.
29. Hill AB The environment and disease: association or causation? Proc R Soc Med. 58:1965;295-300.
30. Dudman NPB, Hicks C, Wang J, Wilcken DEL Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis. 91:1991;77-83.
31. Tsai J, Perella MA, Yoshizumi M, Hsieh C, Haber E, Schlegel R, Lee M Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci. 91:1994;6369-6373.
32. Reiss RF Laboratory diagnosis of erythroid disorders. Tilton RC, Balows A, Hohnadel DC, Reiss RF Clinical Laboratory Medicine. 1992;898-937 Mosby, St. Louis.
33. Stipanuk MH Metabolism of sulfur-containing amino acids. Ann Rev Nutr. 6:1986;179-209.
34. Ubbink JB, Vermaak WJH, Van der Merwe A, Becker PJ Vitamin B-12, vitamin B-6 and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 57:1993;47-53.
35. Ubbink JB, Vermaak WJH, Van der Merwe A, Becker PJ, Delport R, Potgieter HC Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr. 124:1994;1927-1933.
36. Reis RP, Azinheira J, Reis HP, Pereira M, Baptista A, Crespo M, Pina JE, Ferreira C, Luis AS Homocysteinemia as a risk factor in early cerebrovascular disease. Acta Med Port. 7:1994;285-289.